| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34,432 |
32,283 |
$2.30M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
11,357 |
10,792 |
$996K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15,480 |
14,648 |
$951K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
57,422 |
53,775 |
$867K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,534 |
12,870 |
$614K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,698 |
8,196 |
$398K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
9,115 |
8,557 |
$308K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,174 |
1,090 |
$51K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
201 |
189 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,866 |
2,067 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
464 |
435 |
$12K |
| 81000 |
|
2,472 |
2,305 |
$7K |
| 87634 |
|
28 |
28 |
$2K |
| 86318 |
|
243 |
232 |
$2K |
| 73610 |
|
12 |
12 |
$336.62 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
19 |
17 |
$179.11 |
| 81025 |
|
12 |
12 |
$97.83 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
264 |
240 |
$52.27 |
| 99072 |
|
29 |
28 |
$36.06 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
224 |
209 |
$2.16 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
33 |
31 |
$0.00 |